Follow-up of four narcolepsy patients treated with intravenous immunoglobulins

Annals of Neurology

Volumn 60, Issue 1, 2006, Pages 153-

  Dauvilliers, Yves ^a  

^a GUI DE CHAULIAC HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DQ ANTIGEN; IMMUNOGLOBULIN; MODAFINIL;

ADOLESCENT; ADULT; AUTOIMMUNITY; CASE REPORT; CATAPLEXY; EPWORTH SLEEPINESS SCALE; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; LETTER; MALE; NARCOLEPSY; PRIORITY JOURNAL;

ADOLESCENT; ADULT; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MALE; MIDDLE AGED; NARCOLEPSY; TREATMENT OUTCOME;

EID: 33745714458     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.20892     Document Type: Letter

References (3)

1. Peyron C, Faraco J, Rogers W, et al. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 2000;6:991-997.
2. Mignot E, Lin L, Rogers W, et al. Complex HLA DR and DQ interactions confer risk of narcolepsy cataplexy in three ethnic groups. Am J Hum Genet 2001;68:686-699.
3. Dauvilliers Y, Carlander B, Rivier F, et al. Successful management of cataplexy with intravenous immunoglobulins shortly after narcolepsy onset. Ann Neurol 2004;56:905-908.